Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 24 min ago
Peer-reviewedCC BY-NC 4.0International Journal of Chronic Obstructive Pulmonary Disease

Case Finding for COPD in Nottingham and District (C FIND COPD). A Pilot Study of Uptake, Acceptability and Diagnostic Yield in a One-Stop Assessment Following Lung Cancer Screening

4 affiliations
  1. 1Centre for Respiratory Research, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK
  2. 2NIHR Nottingham Biomedical Research Centre, Nottingham, UK
  3. 3Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK
  4. 4Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK

Abstract

Background: Several lung cancer screening (LCS) programmes have identified a high prevalence of people with new (often pre-bronchodilator) airflow obstruction, but demonstrable translation into confirmed chronic obstructive pulmonary disease (COPD) diagnosis is limited. We evaluated a community-based, one-stop, post-bronchodilator case-finding and initial management pathway following LCS.

Methods: Participants undergoing low-dose computed tomography (LDCT) as part of a LCS programme who reported respiratory symptoms were invited to attend a community-based assessment. The pathway included post-bronchodilator spirometry, clinical review and initial management delivered within a single encounter. The primary outcomes were uptake and new clinical diagnosis of COPD. Secondary outcomes included symptom burden, relationship to CT findings, socioeconomic variation and participant-reported experience.

Results: Of 2860 invitation letters issues, 529 (18.5%) invitees participated; a further 33 participants self-presented. Of 562 participants overall, 486 completed spirometry, including 407 without a prior COPD diagnosis. Of these, 100 (25%) participants received a new clinical diagnosis of COPD, mainly with mild-to-moderate airflow obstruction. Among participants with a COPD Assessment Test (CAT) score ≥10, Medical Research Council (MRC) dyspnoea score ≥2, or clinician-defined respiratory symptoms, 35%, 34%, and 38%, respectively, had airflow obstruction. Moderate-to-severe CT emphysema was highly specific but poorly sensitive for airflow obstruction. We detected no significant difference in new COPD diagnosis across deprivation quintiles. Participant-reported experience was very positive.

Conclusion: A community-based, one-stop pathway following LCS can identify clinically meaningful COPD diagnosis in symptomatic individuals. This single encounter approach addresses a key gap in current LCS-linked pathways, maximising opportunities for case finding and supporting accessible, patient-centred diagnostic services.

Related

  1. Improving Immediate Postpartum Detection of Obstetric Anal Sphincter Injury: Added Diagnostic Value of Impedance Spectroscopy Following Clinical Assessment
    M. Uchman Musielak, K. Kleczkowska, I. Sudol Szopinska +1
    medRxivPreprintAll rights reservedFull text1 citedObstetrics, gynaecology & paediatricsmedRxiv
  2. Performance Assessment of an Artificial Intelligence System Used for Case Detection in a Large Community-based Diabetic Retinopathy Screening Program: A Retrospective Diagnostic Accuracy Validation Study.
    Maria Kristina Dg Eduardo, Junn R Pajarillo
    Acta medica PhilippinaPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCPMC
  3. F-OGS, a new “Follow-up Onco-Geriatric Screening” tool during the follow-up of older patients undergoing oncological treatment. Pilot study of feasibility and acceptability
    Simon Valero, Anaïs Fazilleau, Joe de Keizer +5
    Journal of Geriatric OncologyPeer-reviewedLicence not stated1 citedGeneral biologyOncologyHAL
  4. The Master Adaptive Learner Behavioral Assessment Scale (MAL BAS): Development, Validity Evidence, Feasibility, and Acceptability of a New Instrument
    Wing Fu, Tricia R. Prokop, Rosa Elena Torres-Panchamé
    Medical Science EducatorPeer-reviewedLicence not statedFull textEpidemiology & public healthPMC
  5. Ensuring quality in research, 'Authorship Effect' & Conflict of Interest. Response submitted to BMJ Mental Health in response to 'Clinician perspectives on the utility and acceptability of OxSATS: a qualitative study of a novel structured suicide risk assessment tool
    Alastair Cockburn, Karen Lascelles, Leah Quinlivan
    PsyArXivPreprintCC BY 4.0Full textPsychiatry & mental healthOSF
BibTeX
@article{burzic2026case,
  title = {{Case Finding for COPD in Nottingham and District (C FIND COPD). A Pilot Study of Uptake, Acceptability and Diagnostic Yield in a One-Stop Assessment Following Lung Cancer Screening}},
  author = {Amna Burzic and Malik Hamrouni and Joanne Porte and Ayushman Gupta and Rachael L Murray and Tricia M McKeever and Emma O’Dowd and Charlotte E Bolton},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2026},
  month = oct,
  doi = {10.2147/copd.s634297},
  url = {https://doi.org/10.2147/copd.s634297},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Case Finding for COPD in Nottingham and District (C FIND COPD). A Pilot Study of Uptake, Acceptability and Diagnostic Yield in a One-Stop Assessment Following Lung Cancer Screening
AU  - Amna Burzic
AU  - Malik Hamrouni
AU  - Joanne Porte
AU  - Ayushman Gupta
AU  - Rachael L Murray
AU  - Tricia M McKeever
AU  - Emma O’Dowd
AU  - Charlotte E Bolton
PY  - 2026
DA  - 2026/10/31
JO  - International Journal of Chronic Obstructive Pulmonary Disease
DO  - 10.2147/copd.s634297
UR  - https://doi.org/10.2147/copd.s634297
AB  - Background: Several lung cancer screening (LCS) programmes have identified a high prevalence of people with new (often pre-bronchodilator) airflow obstruction, but demonstrable translation into confirmed chronic obstructive pulmonary disease (COPD) diagnosis is limited. We evaluated a community-based, one-stop, post-bronchodilator case-finding and initial management pathway following LCS.  Methods: Participants undergoing low-dose computed tomography (LDCT) as part of a LCS programme who reported respiratory symptoms were invited to attend a community-based assessment. The pathway included post-bronchodilator spirometry, clinical review and initial management delivered within a single encounter. The primary outcomes were uptake and new clinical diagnosis of COPD. Secondary outcomes included symptom burden, relationship to CT findings, socioeconomic variation and participant-reported experience.  Results: Of 2860 invitation letters issues, 529 (18.5%) invitees participated; a further 33 participants self-presented. Of 562 participants overall, 486 completed spirometry, including 407 without a prior COPD diagnosis. Of these, 100 (25%) participants received a new clinical diagnosis of COPD, mainly with mild-to-moderate airflow obstruction. Among participants with a COPD Assessment Test (CAT) score ≥10, Medical Research Council (MRC) dyspnoea score ≥2, or clinician-defined respiratory symptoms, 35%, 34%, and 38%, respectively, had airflow obstruction. Moderate-to-severe CT emphysema was highly specific but poorly sensitive for airflow obstruction. We detected no significant difference in new COPD diagnosis across deprivation quintiles. Participant-reported experience was very positive.  Conclusion: A community-based, one-stop pathway following LCS can identify clinically meaningful COPD diagnosis in symptomatic individuals. This single encounter approach addresses a key gap in current LCS-linked pathways, maximising opportunities for case finding and supporting accessible, patient-centred diagnostic services.
SN  - 1176-9106
SN  - 1178-2005
ER  -